1,2-dipalmitoylphosphatidylcholine has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arieli, R; Bukovetzky, E; Gottfried, OD; Khatib, S; Khattib, A | 1 |
| Fuller, GG; Hsu, TT; Leiske, DL; Rosenfeld, L; Sonner, JM | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Is the probable spillage of the lung surfactant dipalmitoylphosphatidylcholine the ultimate source of diabetes type 1?
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adolescent; Adult; Child; Diabetes Mellitus, Type 1; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lung; Male; Surface-Active Agents; Young Adult | 2021 |
3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness.
Topics: 1,2-Dipalmitoylphosphatidylcholine; 3-Hydroxybutyric Acid; Anesthetics; Cell Membrane; Consciousness; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug | 2013 |